Comparison of prostatic urethral lift (PUL) versus water vapour thermal therapy (WVTT): A focus on drug‐free status and unplanned admissions
BJUI Compass · 2026-07 · 7 (7)
DOI: 10.1002/bco2.70242 ↗At a glance
Journal article in BJUI Compass, published online on 2026-07-03. Written by Athena Y H Lee and 9 co-authors. Institution: S.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine The Chinese University of Hong Kong Hong Kong China. 36 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Objectives
To compare prostatic urethral lift (PUL) and water vapour thermal therapy (WVTT) for benign prostatic hyperplasia (BPH) in a real‐world setting, this study compares clinical management outcomes that are less thoroughly documented in current literature—such as drug‐free status, complications and post‐procedure readmission rates. Patients and methods BPH patients (age ≥50) with prostate volumes 30–80 cc who underwent either PUL or WVTT between January 2021 and December 2024 were identified. Patients were given BPH medications (alpha‐blockers and/or 5‐alpha reductase inhibitors) till 3 months postoperatively. The two groups were matched using a 1:3 propensity score matching; multivariable logistic regression analyses were performed on the full unmatched cohort. The primary outcome is drug‐free status, defined as the cessation of alpha‐blockers and 5‐alpha reductase inhibitors at 6 months post‐procedure. Secondary outcomes include unplanned readmission within 30 days.
Results
In total, 421 eligible patients were analysed (363 WVTT; 58 PUL). In propensity score matched analyses (174 WVTT; 58 PUL), patients were more likely to be drug‐free after PUL at 6 months compared to WVTT (weighted OR: 2.62 [95% CI: 1.22–5.61], p = 0.013). The association remained significant in multivariable regression analysis (adjusted OR: 2.41 [95% CI: 1.31–4.58], p = 0.006). No statistically significant difference in 30‐day readmission rates was found between the two groups in either the propensity score ( p = 0.097) or multivariable analysis ( p = 0.123).
Conclusion
In this retrospective propensity‐score‐matched study, PUL was associated with less BPH medication use at 6 months; readmission rates were comparable for PUL and WVTT.
Subjects
Author keywords
Authors and institutions
- S.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine The Chinese University of Hong Kong Hong Kong China.
ORCID profiles: Athena Y H Lee, Chi Ho Leung, Jeremy Y C Teoh, Peter K F Chiu, Ka Lun Lo
Cite
APA
Lee, A. Y. H., Siu, B. W. H., Tsang, K. H. Y., Leung, C. H., Ho, J. M. H., Chan, Y. Y. Y., Teoh, J. Y. C., Chiu, P. K. F., Lo, K. L., & Ng, C. F. (2026). Comparison of prostatic urethral lift (PUL) versus water vapour thermal therapy (WVTT): A focus on drug‐free status and unplanned admissions. BJUI Compass, 7(7). https://doi.org/10.1002/bco2.70242
Vancouver
Lee AYH, Siu BWH, Tsang KHY, Leung CH, Ho JMH, Chan YYY, et al. Comparison of prostatic urethral lift (PUL) versus water vapour thermal therapy (WVTT): A focus on drug‐free status and unplanned admissions. BJUI Compass. 2026;7(7). doi:10.1002/bco2.70242
BibTeX
@article{Lee2026,
author = {Lee, Athena Y H and Siu, Brian W H and Tsang, Kelly H Y and Leung, Chi Ho and Ho, Jeremy M H and Chan, Yvonne Y Y and Teoh, Jeremy Y C and Chiu, Peter K F and Lo, Ka Lun and Ng, Chi Fai},
title = {Comparison of prostatic urethral lift (PUL) versus water vapour thermal therapy (WVTT): A focus on drug‐free status and unplanned admissions},
journal = {BJUI Compass},
year = {2026},
volume = {7},
number = {7},
doi = {10.1002/bco2.70242}
}
EUVIMED